N-acetyl aspartate - A neuronal marker?

Annals of Neurology

Volumn 49, Issue 4, 2001, Pages 423-424

  Barker, Peter B ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

N ACETYLASPARTIC ACID;

CANAVAN DISEASE; EDITORIAL; GROWTH RETARDATION; HUMAN; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ASPARTIC ACID; BIOLOGICAL MARKERS; BRAIN; CHILD, PRESCHOOL; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; NERVOUS SYSTEM DISEASES; PROTONS;

EID: 0035067040     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.90     Document Type: Editorial

References (21)

1. Absence of N-acetylaspartate in the human brain: Impact on neurospectroscopy?
2. Creatine deficiency in the brain: A new, treatable inborn error of metabolism
3. Diffuse white matter disease in three children: An encephalopathy with unique features on magnetic resonance imaging and proton magnetic resonance spectroscopy
4. Childhood ataxia with diffuse central nervous system hypomyelination
5. A new leukoencephalopathy with vanishing white matter
6. Leukoencephalopathy associated with a disturbance in the metabolism of polyols
7. N-acetyl-L-aspartic acid in brain
8. 1H-NMR spectroscopic studies of brain
9. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies
10. Quantitative in vivo IH nuclear magnetic resonance spectroscopic imaging of neuronal loss in rat brain
11. Histological and 1H magnetic resonance spectroscopic imaging analysis of quinolinic acid-induced damage to the rat striatum
12. Biochemical markers of intelligence: A proton MR spectroscopy study of normal human brain
13. Mast cells contain large quantities of secretagogue-sensitive N-acetylaspartate
14. Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro
15. In vitro expression of N-acetyl aspartate by oligodendrocytes: Implications for proton magnetic resonance spectroscopy signal in vivo
16. SSIEM Award. Aspartoacylase deficiency: The enzyme defect in Canavan disease
17. Reversible decreases in N-acetylaspartate after acute brain injury
18. Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy
19. Normalization of contralateral metabolic function following temporal lobectomy demonstrated by H-1 magnetic resonance spectroscopic imaging
20. Normalization of neuronal metabolic dysphunction after surgery for temporal lobe epilepsy. Evidence from proton MR spectroscopic imaging
21. Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy